166 related articles for article (PubMed ID: 27087167)
1. Role of the protein kinase BRAF in the pathogenesis of endometriosis.
Santulli P; Marcellin L; Chouzenoux S; Boulard V; Just PA; Nicco C; Chereau C; Tosti C; Chapron C; Batteux F
Expert Opin Ther Targets; 2016 Aug; 20(8):1017-29. PubMed ID: 27087167
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase inhibitors can control the progression of endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Arkwright S; Vacher-Lavenu MC; Weill B; Chapron C; Batteux F
J Pathol; 2010 Oct; 222(2):148-57. PubMed ID: 20821752
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of MAPK and VEGFR by Sorafenib Controls the Progression of Endometriosis.
Leconte M; Santulli P; Chouzenoux S; Marcellin L; Cerles O; Chapron C; Dousset B; Batteux F
Reprod Sci; 2015 Sep; 22(9):1171-80. PubMed ID: 26169036
[TBL] [Abstract][Full Text] [Related]
4. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment in vitro.
Matsuzaki S; Darcha C
Hum Reprod; 2015 Jul; 30(7):1606-16. PubMed ID: 25976656
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of BRAF inhibitor vemurafenib in preclinical models of BRAF-mutant colorectal cancer.
Yang H; Higgins B; Kolinsky K; Packman K; Bradley WD; Lee RJ; Schostack K; Simcox ME; Kopetz S; Heimbrook D; Lestini B; Bollag G; Su F
Cancer Res; 2012 Feb; 72(3):779-89. PubMed ID: 22180495
[TBL] [Abstract][Full Text] [Related]
6. The BRAF(V600E) inhibitor, PLX4032, increases type I collagen synthesis in melanoma cells.
Jenkins MH; Croteau W; Mullins DW; Brinckerhoff CE
Matrix Biol; 2015 Oct; 48():66-77. PubMed ID: 25989506
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of anastrozole, methotrexate, and 5-fluorouracil on endometriosis in vitro and in vivo.
Ngô C; Nicco C; Leconte M; Chéreau C; Weill B; Batteux F; Chapron C
Fertil Steril; 2010 Oct; 94(5):1632-8.e1. PubMed ID: 20045515
[TBL] [Abstract][Full Text] [Related]
8. Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells.
Salerno P; De Falco V; Tamburrino A; Nappi TC; Vecchio G; Schweppe RE; Bollag G; Santoro M; Salvatore G
J Clin Endocrinol Metab; 2010 Jan; 95(1):450-5. PubMed ID: 19880792
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.
Trunzer K; Pavlick AC; Schuchter L; Gonzalez R; McArthur GA; Hutson TE; Moschos SJ; Flaherty KT; Kim KB; Weber JS; Hersey P; Long GV; Lawrence D; Ott PA; Amaravadi RK; Lewis KD; Puzanov I; Lo RS; Koehler A; Kockx M; Spleiss O; Schell-Steven A; Gilbert HN; Cockey L; Bollag G; Lee RJ; Joe AK; Sosman JA; Ribas A
J Clin Oncol; 2013 May; 31(14):1767-74. PubMed ID: 23569304
[TBL] [Abstract][Full Text] [Related]
10. The MEK1/2 inhibitor AS703026 circumvents resistance to the BRAF inhibitor PLX4032 in human malignant melanoma cells.
Park SJ; Hong SW; Moon JH; Jin DH; Kim JS; Lee CK; Kim KP; Hong YS; Choi EK; Lee JS; Lee JL; Kim TW
Am J Med Sci; 2013 Dec; 346(6):494-8. PubMed ID: 24051957
[TBL] [Abstract][Full Text] [Related]
11. A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib.
Graziani G; Artuso S; De Luca A; Muzi A; Rotili D; Scimeca M; Atzori MG; Ceci C; Mai A; Leonetti C; Levati L; Bonanno E; Tentori L; Caccuri AM
Biochem Pharmacol; 2015 May; 95(1):16-27. PubMed ID: 25795251
[TBL] [Abstract][Full Text] [Related]
12. Arcyriaflavin a, a cyclin D1-cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis.
Hirakawa T; Nasu K; Aoyagi Y; Takebayashi K; Narahara H
Reprod Biol Endocrinol; 2017 Jul; 15(1):53. PubMed ID: 28720098
[TBL] [Abstract][Full Text] [Related]
13. The BRAFT1799A mutation confers sensitivity of thyroid cancer cells to the BRAFV600E inhibitor PLX4032 (RG7204).
Xing J; Liu R; Xing M; Trink B
Biochem Biophys Res Commun; 2011 Jan; 404(4):958-62. PubMed ID: 21185263
[TBL] [Abstract][Full Text] [Related]
14. The oncogenic BRAF kinase inhibitor PLX4032/RG7204 does not affect the viability or function of human lymphocytes across a wide range of concentrations.
Comin-Anduix B; Chodon T; Sazegar H; Matsunaga D; Mock S; Jalil J; Escuin-Ordinas H; Chmielowski B; Koya RC; Ribas A
Clin Cancer Res; 2010 Dec; 16(24):6040-8. PubMed ID: 21169256
[TBL] [Abstract][Full Text] [Related]
15. Pin1 inhibitor API-1 sensitizes BRAF-mutant thyroid cancers to BRAF inhibitors by attenuating HER3-mediated feedback activation of MAPK/ERK and PI3K/AKT pathways.
Dang H; Sui M; He Q; Xie J; Liu Y; Hou P; Ji M
Int J Biol Macromol; 2023 Sep; 248():125867. PubMed ID: 37473892
[TBL] [Abstract][Full Text] [Related]
16. TNFα-induced IKKβ complex activation influences epithelial, but not stromal cell survival in endometriosis.
Kocbek V; Grandi G; Blank F; Wotzkow C; Bersinger NA; Mueller MD; Kyo S; McKinnon BD
Mol Hum Reprod; 2016 Nov; 22(11):768-777. PubMed ID: 27542948
[TBL] [Abstract][Full Text] [Related]
17. Alteration of Nrf2 and Glutamate Cysteine Ligase expression contribute to lesions growth and fibrogenesis in ectopic endometriosis.
Marcellin L; Santulli P; Chouzenoux S; Cerles O; Nicco C; Dousset B; Pallardy M; Kerdine-Römer S; Just PA; Chapron C; Batteux F
Free Radic Biol Med; 2017 Sep; 110():1-10. PubMed ID: 28457937
[TBL] [Abstract][Full Text] [Related]
18. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells.
Abe W; Nasu K; Nakada C; Kawano Y; Moriyama M; Narahara H
Hum Reprod; 2013 Mar; 28(3):750-61. PubMed ID: 23293219
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic properties of epigallocatechin-3-gallate in endometriosis.
Matsuzaki S; Darcha C
Hum Reprod; 2014 Aug; 29(8):1677-87. PubMed ID: 24876174
[TBL] [Abstract][Full Text] [Related]
20. RG7204 (PLX4032), a selective BRAFV600E inhibitor, displays potent antitumor activity in preclinical melanoma models.
Yang H; Higgins B; Kolinsky K; Packman K; Go Z; Iyer R; Kolis S; Zhao S; Lee R; Grippo JF; Schostack K; Simcox ME; Heimbrook D; Bollag G; Su F
Cancer Res; 2010 Jul; 70(13):5518-27. PubMed ID: 20551065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
